The Cell-Free Fetal DNA  Testing Market is one of the most dynamic segments in the prenatal diagnostics industry, offering a non-invasive approach to early detection of chromosomal abnormalities such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13). This technology, known as non-invasive prenatal testing (NIPT), analyzes fetal DNA...

What’s Fueling the Sudden Surge in Demand for Lab Precision Tools?It’s not a flashy sector — no headlines like biotech breakthroughs or surgical robots. But one niche market is quietly becoming a backbone of diagnostics and research worldwide: the fast-evolving Tissue Sectioning Market. With demand rising across pathology labs, research institutions, and hospitals, precision...